Thumbnail

亚太糖尿病护理设备市场-按产品和地理位置细分-增长、趋势、COVID-19 影响和预测(2021 - 2026 年)

Looking to buy the report?

预计亚太地区糖尿病护理设备市场在 2018-2023 年(预测期)的复合年增长率约为 7.8%。由于该地区存在庞大的糖尿病患者群体,预计中国将在预测期内主导市场。

存在大量糖尿病人群

由于存在大量糖尿病患者,亚太地区是全球市场增长最快的地区。由于存在大量糖尿病患者,中国和印度在亚太地区糖尿病护理设备市场占有主要份额。根据世界卫生组织的数据,世界上超过 60% 的糖尿病患者生活在亚太地区,其中印度和中国是主要的糖尿病发病国,糖尿病人口分别为 9000 万和 6200 万。到 2030 年,这两个国家预计将共同见证大约 50 亿人的糖尿病人口。因此,亚太地区不断增长的糖尿病和肥胖人口正在推动市场增长。此外,关于糖尿病的创新产品开发和意识的提高护理,是进一步推动亚太地区糖尿病护理设备市场的因素。

缺乏适当的报销政策

在印度,大约 10% 的人口享受健康保险,超过 80% 的医疗保健费用是自付费用。

设备制造商在为其产品定价时应了解覆盖范围和人口统计数据,以获取尽可能大的市场份额。对于成熟的医疗产品,如心脏瓣膜、支架等,保障范围已经确定,数据可供保险公司使用。但是,要开发新产品,如血糖仪和糖尿病设备,尚未建立覆盖范围。因此,这些产品只提供给有限的人。因此,亚太发展中国家缺乏报销政策和与糖尿病护理设备相关的高成本可能会阻碍市场增长。

中国主导市场

中国正在主导亚太糖尿病护理设备市场。中国市场的增长可归因于快速城市化、高热量饮食和缺乏运动等因素,这些是中国糖尿病高发的主要原因。预计印度将在预测期内大幅增长。糖尿病患病率的增加、疾病意识的提高、饮食习惯的改变以及该国可支配收入的增加可能会促进印度糖尿病护理设备市场的增长。

                                       

市场的主要发展

  • 2018 年 1 月 - Eli Lilly and Company 与领先的消费者数字健康公司 Livongo Health 达成战略合作,研究现实世界的证据并开发新的见解,以减轻糖尿病患者的负担。
  • 2017 年 6 月——罗氏收购 mySugr,形成领先的数字糖尿病管理开放平台。

主要参与者:Abbott Laboratories、Acon Laboratories, Inc.、Bayer AG、Becton、Dickinson and Company、Eli Lilly & Co.、F. Hoffmann-La Roche Ltd、Johnson and Johnson、Medtronic Plc、Novo Nordisk A/S 和 Sanofi ,等等。

购买本报告的理由

  • 发达市场和新兴市场当前和未来的亚太糖尿病护理设备市场前景
  • 在波特五力分析的帮助下,市场的各种观点
  • 预计将主导市场的细分市场
  • 预计在预测期内增长率最快的地区
  • 主要市场参与者采用的最新发展、市场份额和策略
  • 3 个月的分析师支持,以及市场估算表(Excel 格式)

报告的定制

  • 该报告可以定制以满足您的要求。请与我们的代表联系,他们将确保您获得适合您需求的报告。

1. Introduction

                1.1 Scope of Study

                1.2 Market Definition

                1.3 Executive Summary

2. Research Methodology

                2.1 Study Deliverables

                2.2 Study Assumptions

                2.3 Research Phases

3. Market Insights

                3.1 Technology Trends

                3.2 Industry Attractiveness - Porter's Five Forces Analysis

                                3.2.1 Bargaining Power of the Suppliers

                                3.2.2 Bargaining Power of the Consumers

                                3.2.3 Threat of New Entrants

                                3.2.4 Threat of Substitute Products and Services

                                3.2.5 Competitive Rivalry within the Industry

4. Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

5. Market Segmentation and Analysis

                5.1 Monitoring Device

                                5.1.1 Self Blood Glucose Monitoring

                                                5.1.1.1 Blood Glucose Meters

                                                                5.1.1.1.1 Blood Glucose Meters, Revenue(2012-2023)

                                                                5.1.1.1.2 Blood Glucose Meters, Volume(2012-2023)

                                                5.1.1.2 Blood Glucose Test strips

                                                                5.1.1.2.1 Blood Glucose Test strips, Revenue(2012-2023)

                                                                5.1.1.2.2 Blood Glucose Test strips, Volume(2012-2023)

                                                5.1.1.3 Lancets

                                                                5.1.1.3.1 Lancets, Revenue(2012-2023)

                                                                5.1.1.3.2 Lancets, Volume(2012-2023)

                                5.1.2 Continous Blood Glucose Monitoring

                                                5.1.2.1 Durables

                                                                5.1.2.1.1 Durables, Revenue(2012-2023)

                                                                5.1.2.1.2 Durables, Volume(2012-2023)

                                                5.1.2.2 Sensors

                                                                5.1.2.2.1 Sensors, Revenue(2012-2023)

                                                                5.1.2.2.2 Sensors, Volume(2012-2023)

                5.2 Management Device

                                5.2.1 Insulin Pump

                                                5.2.1.1 Insulin Pump Device

                                                                5.2.1.1.1 Insulin Pump Devices, Revenue(2012-2023)

                                                                5.2.1.1.2 Insulin Pump Devices, Volume(2012-2023)

                                                5.2.1.2 Insulin Pump Reservoir

                                                                5.2.1.2.1 Insulin Pump Reservoirs, Revenue(2012-2023)

                                                                5.2.1.2.2 Insulin Pump Reservoirs, Volume(2012-2023)

                                                5.2.1.3 Infusion Set

                                                                5.2.1.3.1 Infusion Sets, Revenue(2012-2023)

                                                                5.2.1.3.2 Infusion Sets, Volume(2012-2023)

                                5.2.2 Syringes

                                                5.2.2.1 Syringes, Revenue(2012-2023)

                                                5.2.2.2 Syringes, Volume(2012-2023)

                                5.2.3 Cartridges

                                                5.2.3.1 Cartridges, Revenue(2012-2023)

                                                5.2.3.2 Cartridges, Volume(2012-2023)

                                5.2.4 Disposable Pens

                                                5.2.4.1 Disposable Pens, Revenue(2012-2023)

                                                5.2.4.2 Disposable Pens, Volume(2012-2023)

                                5.2.5 Jet Injectors

                                                5.2.5.1 Jet Injectors , Revenue(2012-2023)

                                                5.2.5.2 Jet Injectors , Volume(2012-2023)

5.2.6 Geographical Analysis

                                5.2.6.1 Australia

                                                5.2.6.2 Australia, Revenue (2012-2023)

                                                5.2.7 Australia, Volume (2012-2023)

                                5.2.7.1 India

                                                5.2.7.2 India, Revenue (2012-2023)

                                                5.2.8 India, Volume (2012-2023)

                                5.2.8.1 Indonesia

                                                5.2.8.2 Indonesia, Revenue (2012-2023)

                                                5.2.9 Indonesia, Volume (2012-2023)

                                5.2.9.1 Thailand

                                                5.2.9.2 Thailand, Revenue (2012-2023)

                                                5.2.10 Thailand, Volume (2012-2023)

                                5.2.10.1 Philippines

                                                5.2.10.2 Philippines, Revenue (2012-2023)

                                                5.2.11 Philippines, Volume (2012-2023)

                                5.2.11.1 Vietnam

                                                5.2.11.2 Vietnam, Revenue (2012-2023)

                                                5.2.12 Vietnam, Volume (2012-2023)

                                5.2.12.1 China

                                                5.2.12.2 China, Revenue (2012-2023)

                                                5.2.13 China, Volume (2012-2023)

                                5.2.13.1 South Korea

                                                5.2.13.2 South Korea, Revenue (2012-2023)

                                                5.2.14 South Korea, Volume (2012-2023)

                                5.2.14.1 Japan

                                                5.2.14.2 Japan, Revenue (2012-2023)

                                                5.2.15 Japan, Volume (2012-2023)

                                5.2.15.1 Malaysia

                                                5.2.15.2 Malaysia, Revenue (2012-2023)

                                                5.2.16 Malaysia, Volume (2012-2023)

                                5.2.16.1 Rest of Asia Pacific

                                                5.2.16.2 Rest of Asia Pacific, Revenue (2012-2023)

                                                6. Rest of Asia Pacific, Volume (2012-2023)

7. Key Player Profiles

                7.1 Abbott Diabetes Care

                7.2 Roche

                7.3 Johnson & Johnson

                7.4 Arkray

                7.5 Ascensia Diabetes Care

                7.6 AgaMatrix, Inc.

                7.7 LifeScan

                7.8 Sanofi

                7.9 Dexcom

                7.10 Medtronic

                7.11 Novo Nordisk

                7.12 Becton Dickinson

                7.13 Eli Lilly

                7.14 Ypsomed Holding AG

* Each Company Profile include overview, Revenue, Product and services, Swot, Recent Activities and strategic Analysis.

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy